Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 47 (Search time: 0.023 seconds).
Item hits:
Issue DateTitleAuthor(s)
2006Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminaseBorrell Pagès, Maria; Canals i Coll, Josep M.; Cordelières, Fabrice P.; Parker, J. Alex; Pineda Martí, José Ramón; Grange, Ghislaine; Bryson, Elzbieta A.; Guillermier, Martine; Hirsch, Etienne; Hantraye, Philippe; Cheetham, Michael E.; Néri, Christian; Alberch i Vié, Jordi, 1959-; Brouillet, Emmanuel; Saudou, Frédéric; Humbert, Sandrine
1-Sep-2015Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's diseaseFernández-Nogales, Marta; Hernández, Félix; Miguez, Andrés; Alberch i Vié, Jordi, 1959-; Ginés Padrós, Silvia; Pérez Navarro, Esther; Lucas, José J.
2011Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunctionGiralt Torroella, Albert; Carreton, Olga; Lao-Peregrin, Cristina; Martín, Eduardo D.; Alberch i Vié, Jordi, 1959-
28-May-2020Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease.Fernández García, Sara; Orlandi, Javier G.; García-Díaz Barriga, Gerardo; Rodríguez Allué, Manuel José; Masana Nadal, Mercè; Soriano i Fradera, Jordi; Alberch i Vié, Jordi, 1959-
1-Aug-2019Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus AccumbensBrito, Verónica; Giralt Torroella, Albert; Masana Nadal, Mercè; Royes, Aida; Espina, Marc; Sieiro, Esther; Alberch i Vié, Jordi, 1959-; Castañé, Anna; Girault, Jean-Antoine; Ginés Padrós, Silvia
15-Feb-2012Don’t Take Away My P: Phosphatases as Therapeutic Targets in Huntington’s DiseaseSaavedra, Ana; Alberch i Vié, Jordi, 1959-; Pérez Navarro, Esther
18-Apr-2013Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapiesBrito, Verónica; Puigdellívol Cañadell, Maria del Mar; Giralt Torroella, Albert; Toro, Daniel del; Alberch i Vié, Jordi, 1959-; Ginés Padrós, Silvia
Oct-2018Increased levels of rictor prevent mutant huntingtin-induced neuronal degenerationCreus Muncunill, Jordi; Rué Cabré, Laura; Alcalá Vida, Rafael; Badillos Rodríguez, Raquel; Romaní Aumedes, Joan; Marco, Sonia; Alberch i Vié, Jordi, 1959-; Pérez Otaño, Isabel; Malagelada Grau, Cristina; Pérez Navarro, Esther
31-Oct-2011Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicityXifró i Collsamata, Xavier; Anglada Huguet, Marta; Rué Cabré, Laura; Saavedra, Ana; Pérez Navarro, Esther; Alberch i Vié, Jordi, 1959-
1-Oct-2019Increased translation as a novel pathogenic mechanism in Huntington's diseaseCreus Muncunill, Jordi; Badillos Rodríguez, Raquel; Garcia-Forn, Marta; Masana Nadal, Mercè; García-Díaz Barriga, Gerardo; Guisado Corcoll, Anna; Alberch i Vié, Jordi, 1959-; Malagelada Grau, Cristina; Delgado García, José M.; Gruart i Massó, Agnès; Pérez Navarro, Esther